--(BUSINESS WIRE)--Anova Enterprises, LLC (Anova) is accelerating clinical development with an approach designed to disrupt and transform the traditional drug development model, using SaaS-based technology to enable efficient design, networking, management and conduct of clinical studies. The solution aligns the interests of all stakeholders (biopharmaceutical companies, medical device manufacturers and diagnostics companies, sites, principal investigators, Institutional Review Boards, ancillary service providers and patients), facilitates collaboration between these stakeholders and uses fact-based decision making to drive a learning system that speeds product development, reduces cost and increases the chance of product success (i.e., marketing approval).
|
Company: |
Anova Enterprises, LLC | |||
|
Headquarters Address: |
926 N Beverley Lane | |||
| Arlington Heights, IL 60004-5727 | ||||
|
Main Telephone: |
3104808973 | |||
|
Website: |
||||
|
Type of Organization: |
Private | |||
|
Industry: |
Research & Science | |||
|
Key Executives: |
CEO: Christopher Beardmore |
|||
|
President: Martin Walsh |
||||
|
Public Relations |
||||
|
Contact: |
Christopher Beardmore | |||
|
Phone: |
3104808973 | |||
|
Email: |
||||
|
Investor Relations |
||||
|
Contact: |
Martin Walsh | |||
|
Phone: |
+447976179563 | |||
|
Email: |
